By Dr Sunil Badve

Book Chapters

Jefferis JM; Johnson DW; Badve S, 2023, 'Hyperuricaemia and Chronic Kidney Disease', in Management of Chronic Kidney Disease A Clinicians Guide Second Edition, pp. 81 - 97, http://dx.doi.org/10.1007/978-3-031-42045-0_7

O'Shea S; Badve SV; Johnson DW, 2014, 'Erythropoiesis stimulating agent resistance', in Advances in Drug Resistance Research, pp. 120 - 135

Badve SV; Hawley CM; Johnson DW, 2013, 'How do clinical outcomes of automated peritoneal dialysis compare with those of continuous ambulatory peritoneal dialysis?', in Issues in Dialysis, pp. 85 - 102

Zirapury T; van Eps C; Hawley CM; Badve SV; Johnson DW, 2013, 'An overview of erythropoietin therapy', in Erythropoietin Human Production Potential Uses and Adverse Effects, pp. 31 - 53

Bose B; Badve SV; Johnson DW, 2013, 'Peritoneal transport status: A risk factor for peritoneal dialysis', in Peritoneal Dialysis Types Procedures and Risks Factors, pp. 69 - 94

Badve SV; Hawley CM; Johnson DW, 2012, 'How do clinical outcomes of automated peritoneal dialysis compare with those of continuous ambulatory peritoneal dialysis?', in Issues in Dialysis, pp. 85 - 102

Malasingam R; Johnson DW; Badve SV, 2012, 'Association Between Haemoglobin Variability and Clinical Outcomes in Chronic Kidney Disease', in Novel Insights on Chronic Kidney Disease, Acute Kidney Injury and Polycystic Kidney Disease, IntechOpen, http://dx.doi.org/10.5772/37128

Badve SV; Beller E; Cass A; Francis DP; Hawley C; Macdougall IC; Perkovic V; Johnson DW, 2010, 'Interventions for erythropoietin‐resistant anaemia in dialysis patients', in Badve SV (ed.), Cochrane Database of Systematic Reviews, Wiley, http://dx.doi.org/10.1002/14651858.cd006861.pub2

Journal articles

Mann JFE; Badve SV; Baeres FMM; Belmar N; Brown-Frandsen K; Buse JB; Colhoun HM; Deanfield JE; Engelmann MDM; Hovingh GK; Idorn T; Lincoff AM; Lingvay I; Mahaffey KW; McGuire DK; Pratley RE; Rasmussen S; Rossing P; Sattar N; Tuttle KR; Perkovic V, 2026, 'Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis', Lancet Diabetes and Endocrinology, 14, pp. 818 - 830, http://dx.doi.org/10.1016/S2213-8587(26)00134-8

Heath LE; Badve SV; Yang J; Neuen BL, 2026, 'The challenge of introducing aldosterone synthase inhibitors into multidisciplinary practice', American Journal of Hypertension, 39, pp. S97 - S105, http://dx.doi.org/10.1093/ajh/hpag074

Heerspink HJL; Neuen BL; Agarwal R; Cherney DZI; Lam CSP; Tuttle KR; Wanner C; Sarafidis P; Jongs N; Smeijer JD; Brinker M; Rethemeier N; Schloemer P; Vesterinen P; Goldsbury D; Dizayee S; Mares JW; Perkovic V, 2026, 'Finerenone in Persons with Chronic Kidney Disease without Diabetes', New England Journal of Medicine, 395, pp. 533 - 545, http://dx.doi.org/10.1056/NEJMoa2604625

CHATUR S; FLETCHER RA; YEUNG E; SIRIWARDANA A; HEATH L; VADUGANATHAN M; ARNOTT C; BADVE SV; KOTWAL S; JUN M; JARDINE M; POLLOCK C; HEERSPINK HJL; PERKOVIC V; NEUEN BL, 2026, 'Sodium-glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes and Chronic Kidney Disease Experiencing a Deterioration in Estimated Glomerular Filtration Rate to <20 mL/min/1.73 m2', Journal of Cardiac Failure, 32, pp. 1408 - 1417, http://dx.doi.org/10.1016/j.cardfail.2026.01.020

Badve SV; Perkovic V; Jha V; Ramachandran R; Mushahar L; Menne J; De Vriese AS; Rossignol P; Flahault A; Al Ammari M; Skhiri H; Walsh M; Collister D; Liew A; Billot L; Bompoint S; Devaux A; Jun M; Lin E; Ramos Da Cruz A; Ha JT; Eikelboom JW; Shaman A; Jardine MJ; Jesudason S; Wong MG; Anderson CS; Garg AX; Heerspink HJL; Monaghan H; Patel A; Mark PB; Wheeler DC; Lv J; Zuo L; Pilmore H; Gallagher M, 2026, 'Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial', JAMA, 336, pp. 296 - 305, http://dx.doi.org/10.1001/jama.2026.9379

Neuen BL; Perkovic V; Agarwal R; Cherney DZI; Lam CSP; Wanner C; Tuttle KR; Sarafidis P; Barratt J; Burgner A; Chen X; Chew-Wong A; Dobronravov VA; Floege J; Mccafferty K; Nangaku M; Packham D; Papachristou E; Pergola PE; Speeckaert MM; Subbiah A; Tang SCW; Tang S; Yeo SC; Jongs N; Smeijer JD; Berger M; Brinker M; Dayoub R; Elliott J; Li N; Mueller K; Rethemeier N; Finkelsztein MY; Heerspink HJL, 2026, 'Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical Trial', JAMA, 336, pp. 224 - 235, http://dx.doi.org/10.1001/jama.2026.9923

Wallace H; Buizen L; Badve SV; Ha JT; Ketema DB; Ronksley P; Sasaki T; Siriwardana A; Harris K; Henry A; Woodward M; Kotwal SS; Jun M, 2026, 'Sex differences in patterns of chronic kidney disease care in Australian primary care: A retrospective cohort study of a national general practice dataset', Diabetes Obesity and Metabolism, 28, pp. 2329 - 2338, http://dx.doi.org/10.1111/dom.70428

Perkovic V; Trimarchi H; Tesar V; Lafayette R; Wong MG; Barratt J; Suzuki Y; Liew A; Zhang H; Carroll K; Jha V; Quevedo A; Han SH; Praga M; Chacko B; Sahay M; Cheung CK; Kooienga L; Walsh M; Xia J; Fajardo C; Shah L; Hafkin J; Rizk DV, 2026, 'Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial', New England Journal of Medicine, 394, pp. 635 - 646, http://dx.doi.org/10.1056/NEJMoa2512133

Sasaki T; Buizen L; Harris K; Badve SV; Chalmers J; Gallagher M; Ha JT; Jardine MJ; Ketema DB; Kotwal SS; Neuen BL; Ronksley PE; Wallace H; Yokoo T; Woodward M; Jun M, 2026, 'Variability in eGFR and the Risk of Adverse Kidney Outcomes and All-Cause Mortality: A Retrospective Observational Study Based on National General Practice Dataset', Kidney360, 7, pp. 312 - 320, http://dx.doi.org/10.34067/KID.0000000988

HA JT; FLETCHER RA; ARNOTT C; JUN M; KOTWAL SS; PERKOVIC V; BADVE SV; NEUEN BL, 2026, 'Albuminuria, Kidney Function and Heart Failure Risk in Type 2 Diabetes: Participant-level Pooled Analysis from the CANVAS Program and CREDENCE Trial', Journal of Cardiac Failure, 32, pp. 151 - 156, http://dx.doi.org/10.1016/j.cardfail.2025.05.021

Karsten M; Badve SV; Gansevoort RT; Berger SP; Heerspink HJL; Abrahams AC; Billot L; Bon RHACM; Gelens MACJ; Guinness D; Hamilton-Craig C; van Heerebeek L; Hemmelder MH; Houston L; Kozor R; Kuypers DRJ; Monaghan H; Neal B; Neuen BL; Otton J; Perkovic V; Rajwani A; Wang AY; Vervloet MG; Arnott C; Jakulj L; van Etten R; Francois K; Gois P; van der Heijden J; Holt J; Jesudason S; Keung K; Kim YS; Krishnasamy R; Kulkarni H; van der Leeuw J; Makris A; Masterson R; Mather A; Ocak G; Palamuthusingam D; Pedagogos E; Siegert C; Smyth B; Srivastava V; Talaulikar G; Vleut R; Waanders F; Wong G; Wong MG; Wyburn K, 2026, 'Cardiac impact of dapagliflozin in advanced chronic kidney disease: rationale and design of the Renal Lifecycle Trial cardiac imaging sub-studies', Clinical Kidney Journal, 19, http://dx.doi.org/10.1093/ckj/sfaf376

Badve SV; De Vriese AS; Gallagher M, 2026, 'Low-Dose Rivaroxaban, Cardiovascular Events, and Kidney Disease— In Reply', JAMA, http://dx.doi.org/10.1001/jama.2026.16113

Badve SV; Al Ammari M; Anderson CS; Billot L; Bompoint S; Collister D; De Vriese AS; Eikelboom JW; Flahault A; Garg AX; Ha JT; Heerspink HJL; Jardine MJ; Jesudason S; Jha V; Jun M; Landrigan J; Liew A; Lin E; Lv J; Mark PB; Menne J; Monaghan H; Mushahar L; Patel A; Pilmore H; Perkovic V; Ramachandran R; Rossignol P; Shaman A; Skhiri H; Walsh M; Wheeler DC; Wong MG; Zuo L; Gallagher M, 2026, 'Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial', American Journal of Nephrology, pp. 1 - 11, http://dx.doi.org/10.1159/000550796

Pedagogos E; Chen R; Nelson A; Badve S; Rasalam R; MacIsaac R, 2026, 'Semaglutide in type 2 diabetes and chronic kidney disease in Australia: practical clinical considerations from a multidisciplinary panel', Internal Medicine Journal, http://dx.doi.org/10.1111/imj.70647

Hanberg JS; Zhang Y; Kronbichler A; Matyjek A; McAlear C; Odler B; Uchida L; Geetha D; Hawley C; Jayne D; Walsh M; Merkel PA; Wallace ZS, 2026, 'Longitudinal Trajectories of Kidney Function in Patients with Severe ANCA-Associated Vasculitis', Clinical Journal of the American Society of Nephrology, 21, pp. 283 - 295, http://dx.doi.org/10.2215/cjn.0000000881

Fan L; Wong MG; Chen W; Ye Z; Jardine M; Badve S; Billot L; Tan N; Monaghan H; Chen M; Coggan S; Kotwal S; Ma G; Perkovic V; Yu X, 2026, 'WCN26-5467 ASPIrin to Reduce Events in Dialysis (ASPIRED) trial: a pragmatic, registry-based, double-blind randomized clinical trial', Kidney International Reports, 11, pp. 104237, http://dx.doi.org/10.1016/j.ekir.2026.104237

Lam D; Scaria A; Andrade J; Badve SV; Birks P; Bota SE; Campain A; Djurdjev O; Garg AX; Harel Z; Hemmelgarn B; Hockham C; James MT; Jardine MJ; Levin A; McArthur E; Ravani P; Shao S; Sood MM; Tan Z; Tangri N; Whitlock R; Gallagher M; Jun M; Ha JT, 2025, 'Safety and Effectiveness of Apixaban versus Warfarin by Kidney Function in Atrial Fibrillation', Kidney360, 6, pp. 1510 - 1521, http://dx.doi.org/10.34067/KID.0000000809

Chatur S; Heath L; Fletcher RA; Arnott C; Badve SV; Kotwal S; Vaduganathan M; Jun M; Jardine M; Heerspink H; Perkovic V; Neuen B, 2025, 'Canagliflozin in patients with type 2 Diabetes and CKD experiencing deterioration in eGFR to <20 ml/min/1.73m2 in the CREDENCE Trial', European Heart Journal, 46, http://dx.doi.org/10.1093/eurheartj/ehaf784.4190

Wallace H; Wick J; Neuen BL; Buizen L; Badve SV; Chalmers J; de Oliveira Costa J; Falster MO; Ha JT; Jardine MJ; Ketema DB; Lin J; Nelson C; Pearson SA; Peiris D; Rodgers A; Sasaki T; Woodward M; Gallagher M; Kotwal SS; Ronksley P; Jun M, 2025, 'Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset', Diabetes Obesity and Metabolism, 27, pp. 5599 - 5611, http://dx.doi.org/10.1111/dom.16608

Ketema DB; Wallace H; Hailu W; Badve SV; Ronksley P; Neuen BL; Pecoits-Filho R; Gallagher M; Kotwal S; Perkovic V; Joshi R; Jun M, 2025, 'Quality of care for people with chronic kidney disease: a systematic review and meta-analysis', BMJ Open, 15, http://dx.doi.org/10.1136/bmjopen-2025-102044

Bakker WM; Heerspink HJL; Berger SP; Wanner C; Badve SV; Arnott C; Abrahams AC; Van Den Born JC; Van Faassen TC; Gaillard CAJM; Gelens MACJ; Górris JL; Hemmelder MH; Jakulj L; Van Kruijsdijk RCM; Kuypers DRJ; Van Der Meer P; Van Der Net JB; Nijmeijer HH; Vervloet MG; De Vries APJ; Walsh M; Wang AY; Gansevoort RT; Adema AY; Alphen AM; Bax WA; Bayrak J; Boom H; Boonstra AH; Brinkman N; De Maar E; De Waal Y; Eshuis M; Hermans M; Hesselink DA; Hoogeveen EK; Huitema J; Jansen WMT; Jonker JT; Keet SWM; Konings S; Later A; Leurs P; Logtenberg S; Luik P; Ocak G; Ozyilmaz A; Rood J; Schouten M; Siddiqi-Nadery L; Siegert C; Slebe J; Stifft F; Van Bemmel T; Van Breda GF; Van Der Heijden J; Van Der Leeuw J; Van Eck Van Der Sluijs A; Van Etten R; Van Mil D; Waanders F; Wiegersma JS; Banas B; Budde K; Busch M; Girndt M; Guthoff M; Herzog AL; Hohenstein B; Schiffer M; Schlieper G; Schömig M; Schröppel B; Seeger W; Stegbauer J; Strutz F; Wanner C; Weinmann-Menke J; Zeier M; Holt J; Jesudason S; Keung K; Krishnasamy R; Kulkarni H; Makris A; Masterson R; Mather A; Palamuthusingam D; Pedagogos E; Smyth B; Srivastava V; Talaulikar G; Wong G; Wong M; Wyburn K; Dejagere T; Francois K; Lemahieu W; Mahieu E, 2025, 'Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney disease', Nephrology Dialysis Transplantation, 40, pp. 1746 - 1755, http://dx.doi.org/10.1093/ndt/gfaf046

Jeyaruban A; Bose B; Lee VW; Jardine M; Mallawaarachchi A; Ritchie A; Wong MG; Makris A; Badve SV; Siriwardana A; Yong K; Perkovic V; Kotwal S, 2025, 'Glomerular disease registry and biobank: design and baseline results', Internal Medicine Journal, 55, pp. 1301 - 1307, http://dx.doi.org/10.1111/imj.70056

Harel Z; Smyth B; Badve SV; Blum D; Beaubien-Souligny W; Silver SA; Clark E; Suri R; Mavrakanas TA; Sasal J; Prasad B; Eikelboom J; Tennankore K; Rigatto C; Prce I; Madore F; Mac-Way F; Steele A; Zeng Y; Sholzberg M; Dorian P; Yan AT; Sood MM; Gladstone DJ; Tseng E; Kitchlu A; Walsh M; Sapir D; Oliver MJ; Krishnan M; Kiaii M; Wong N; Kotwal S; Battistella M; Acedillo R; Lok C; Weir M; Wald R, 2025, 'Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis: A Pilot Randomized Controlled Trial', Journal of the American Society of Nephrology, 36, pp. 901 - 910, http://dx.doi.org/10.1681/ASN.0000000000000495

Lee MMY; Sattar N; Pop-Busui R; Deanfield J; Emerson SS; Inzucchi SE; Mann JFE; Marx N; Mulvagh SL; Poulter NR; Badve SV; Pratley RE; Perkovic V; Buse JB; McGuire DK, 2025, 'Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials', Diabetes Care, 48, pp. 846 - 859, http://dx.doi.org/10.2337/dc25-0241

Greene T; Collier W; Haaland B; Zhang C; Badve SV; Caravaca-Fontán F; Del Vecchio L; Floege J; Hannedouche T; Imai E; Jafar TH; Lewis JB; Li PKT; Locatelli F; Maes BD; Neuen BL; Perrone RD; Schena FP; Toto R; Wanner C; Woodward M; Van Zuilen A; Heerspink HJL; Inker LA; Estacio RO; Hanratty R; Chalmers J; Parving HH; Appel GB; Canetta P; Brenner BM; Barrett B; Neal B; Mahafey KW; Neuen B; Johnson D; Perkovic V; Mahaffey KW; Jardine M; Fervenza F; Von Eynatten M; Goicoechea M; Verde E; Verdalles U; Arroyo D; Chapman A; Torres V; Yu A; Brosnahan G; Kam-Tao Li P; Chow KM; Szeto CC; Leung CB; Xie D; Hou FF; Dwyer J; Pohl M; Raz I; Hunsicker L; Becker GJ; Ihle BU; Kincaid-Smith PS; Kamper A; Katafuchi R; Vanacker A; Malfait T; Maschio G; Van Kruijsdijk R; Vernooij RWM; Kobayashi F; Makino H; Chan JCN; Passerini P; Andrulli S; Pozzi C; Casartelli D; Praga M; Trujillo H; Cavero T; Sevillano A; Ruggenenti P; Perna A; Carrara F; Gherardi G; Keane WF; Manno C; Haynes R; Herrington WG; Baigent C; Landray M; Rauen T; Seikrit C; Wied S; De Zeeuw D; De Jong PE; Saddelli M; Zucchelli P, 2025, 'Clinical Implications of Slope of GFR in Clinical Trials of CKD Progression', Clinical Journal of the American Society of Nephrology, 20, pp. 632 - 641, http://dx.doi.org/10.2215/CJN.0000000662

Wallace H; Wick J; Ketema DB; Buizen L; Woodward M; Peiris D; Neuen BL; Robertson C; Nelson C; Chalmers J; Badve SV; Kotwal SS; Ronksley P; Gallagher M; Jun M, 2025, 'Assessing patterns of chronic kidney disease care in Australian primary care: a retrospective cohort study of a national general practice dataset', Lancet Regional Health Western Pacific, 57, http://dx.doi.org/10.1016/j.lanwpc.2025.101541

Koshino A; Heerspink HJL; Jongs N; Badve SV; Arnott C; Neal B; Jardine M; Mahaffey KW; Pollock C; Perkovic V; Hansen MK; Bakker SJL; Wada T; Neuen BL, 2025, 'Canagliflozin and iron metabolism in the CREDENCE trial', Nephrology Dialysis Transplantation, 40, pp. 696 - 706, http://dx.doi.org/10.1093/ndt/gfae198

Chan B; Varghese A; Badve SV; Pecoits-Filho R; Guedes M; Arnott C; Kozor R; O'Lone E; Jun M; Kotwal S; Block GA; Chertow GM; Solomon SD; Vaduganathan M; Perkovic V; Neuen BL, 2025, 'Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKD', Kidney International Reports, 10, pp. 1037 - 1049, http://dx.doi.org/10.1016/j.ekir.2025.01.029

Heerspink HJL; Agarwal R; Bakris GL; Cherney DZI; Lam CSP; Neuen BL; Sarafidis PA; Tuttle KR; Wanner C; Brinker MD; Dizayee S; Kolkhof P; Schloemer P; Vesterinen P; Perkovic V; Bittar J; Zaidman CJ; Cluigt N; Hominal M; Aguerre P; Halac F; Gelersztein E; Arriola M; Maldonado R; Chahin M; Packham D; Lee D; Pedagogos E; Foote C; Badve S; Hawley C; Chen J; Gray N; Speeckaert M; Labriola L; Doubel P; Maes B; Claes K; Dubois B; Dimitrova I; Vutova T; Ilchev S; Stamova S; Ivanova Y; Vasileva A; Chen X; Tang S; Xu X; Liu B; He W; He Y; Liu F; Wang C; Chen L; Niu J; Wang D; Luo P; Xia Y; Jiang G; Luo Q; Wang F; Chen M; Lin H; Yan R; Li Y; Chen Q; Dong J; Xiong F; Long H; Cheng H; Li Y; Du J; Liu F; Chen Q; Lu W; Chen C; Wang J; Liu L; Yang M; Long G; Shi Y; Li W; Yang X; Yang A; Li J; Meng X; Prazny M; Hornova L; Bucek P; Majernikova M; Wirth J; Rehorova J; Hornum M; Bech J; Lindhardt M; Hansen D; Mortensen L; Juhl C; Boletis I; Papadopoulou D, 2025, 'Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial', Nephrology Dialysis Transplantation, 40, pp. 308 - 319, http://dx.doi.org/10.1093/ndt/gfae132

Collister D; Pyne L; Bhasin AA; Smyth B; Herrington W; Jardine M; Mark PB; Badve S; Rossignol P; Dember LM; Wanner C; Ezekowitz J; Devereaux PJ; Parfrey P; Gansevoort R; Walsh M, 2025, 'Heart failure events in randomized controlled trials for adults receiving maintenance dialysis: a meta-epidemiologic study', Nephrology Dialysis Transplantation, 40, pp. 371 - 384, http://dx.doi.org/10.1093/ndt/gfae156

Badve SV; Bilal A; Lee MMY; Sattar N; Gerstein HC; Ruff CT; McMurray JJV; Rossing P; Bakris G; Mahaffey KW; Mann JFE; Colhoun HM; Tuttle KR; Pratley RE; Perkovic V, 2025, 'Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials', Lancet Diabetes and Endocrinology, 13, pp. 15 - 28, http://dx.doi.org/10.1016/S2213-8587(24)00271-7

Mann JF; Badve S; Baeres FMM; Belmar N; Brown-Frandsen KS; Buse J; Colhoun H; Deanfield J; Engelmann MDM; Hovingh K; Idorn T; Lincoff AM; Lingvay I; Mahaffey KW; McGuire DK; Pratley RE; Rasmussen S; Rossing P; Sattar N; Tuttle KR; Perkovic V, 2025, 'Effect of Semaglutide on Kidney Outcomes: Pooled Analysis of the SELECT, FLOW, and SOUL Trials', Journal of the American Society of Nephrology, 36, pp. 10.1681/asn.2025vd9epqq7, http://dx.doi.org/10.1681/asn.2025vd9epqq7

Kotwal SS; Jeyaruban AS; Bose B; Lee VWS; Jardine M; Mallawaarachchi A; Ritchie AG; Wong MG; Makris A; Badve S; Siriwardana A; Yong K; Perkovic V, 2025, 'Glomerular Disease Registry and Biobank: Baseline and Follow-Up Results', Journal of the American Society of Nephrology, 36, pp. 10.1681/asn.2025a2e9nynn, http://dx.doi.org/10.1681/asn.2025a2e9nynn

Ha J; Buizen L; Wallace H; Ketema D; Sasaki T; Arnott C; Badve S; Costa J; Falster M; Gallagher M; Milder T; Pearson S; Kotwal S; Ronksley P; Woodward M; Neuen B; Jun M, 2025, 'Prevalence, Overlap, and Treatment of Cardiovascular-Kidney-Metabolic Conditions in Australian Primary Care: Estimates From a National General Practice Dataset', Heart Lung and Circulation, 34, pp. s529, http://dx.doi.org/10.1016/j.hlc.2025.06.676

Odler B; Riedl R; Geetha D; Szpirt WM; Hawley C; Uchida L; Wallace ZS; Walters G; Muso E; Tesar V; Pusey CD; Little MA; Merkel PA; Walsh M; Jayne DRW; Kronbichler A; Paizis K; Walters G; Jardine M; Milton C; Ibraham A; Siva B; Desmond M; Perkovic V; Kurtkoti J; Vilayur E; Cass A; Summers S; Brown F; Ryan J; Kerr P; Noble E; Luxton G; Mudge DW; Hawley C; Johnson DW; Peh CA; Faull RJ; Ranganathan D; Jeffs L; Nicholls K; Hughes P; Cooper B; Boudville N; Ford S; Langham R; Reidlinger D; AliciaMorrish ; Badve SV; Pascoe E; Paul-Brent P-A; Robison L; Valks A; Blockmans D; Henckaerts L; Sprangers B; Suri R; Brachemi S; Clark W; Garg A; Carette S; Pagnoux C; Reich H; Barth D; Walsh M; Khalidi N; Cox G; Mazzetti A; Robins D; Wald R; Perl J; Pavenski K; Dacouris N; Levin A; Copland M; Fairhead T; Pannu N; Qarni MU; Habib S; Girard L; Manns B; Tesar V; Hruskova Z; Chocova Z; Povlsen J; Gregersen J; Ivarsen P; Birn H; Krarup E; Pedersen EB; Thomsen I; Bech JN; Szpirt W; Egfjord M; Mesbah R; Bataille P; Rey I; Chantrel F; Vanhille P; Quémeneur T; Carron P-L; Zaoui P; de Moreuil C; Gosselin M; Delluc A; Hanrotel-Saliou C; Le Jeune M; Ficheux M; Aniort J; Lavigne C; Augusto JF; Chauveau D; Guitard J; Huart A; Ribes D; Gatault P; Becmeur C; Muller S; Betz V; Klein A; Blaison G; Seror R; Francois H; Mariette X; Aubrun A; Coustet B; Palazzo E; Ottaviani S; Goulenok T; Daugas E; Dieudé P; Papo T; Lebas C; Lionet A; Guillevin L; Mouthon L; Puéchal X; Jourde-Chiche N; Ruivard M; Karras A; Limal N; Kofman T; Le Quellec A; Maurier F; Gibelin A; Parrot A; Bachmeyer C; Gombert B; Nouvier M; Lega J-C; Fain O; Andrès E; Cottet R; Gregorini G; Jeannin G; Possenti S; Buzio C; Vaglio A; Oliva E; Makino H; Muso E; Endo T; Kakita H; Suzuki H; Handa T; Kang Y; Ariyasu Y; Tsukamoto T; Endo S; Miyata H; Yamada H; Ito-Ihara T; Uchida S; Kono H; Fujigaki Y; Kikuchi H; Nanki T; Kato H; Okamoto A; Asako K; Suzuki K; Hamano Y; Yamagata K; Usui J; Fujimoto S; Sato Y; Kikuchi M; Flores-Suárez LF; Sánchez-Guerrero SA; Collins M; Schollum J; de Zoysa J; Quincy V; Sizeland P; Aasarod K; Solbu M; Bruun TJ; Koldingsnes W; Wludarczyk A; Nowak I; Gorka J; Sznajd J; Padjas A; Jankowski M; Widawska A; Szczeklik W; Ballarin J; Bruchfeld A; Efvergren M; Eriksson P; Westman K; Selga D; Heijl C; Ohlsson S; Segelmark M; Basu N; Kidder D; Fluck N; Jayne DRW; Smith R; Wilcocks L; McClure M; Jones R; Trivedi S; Gopaluni S; Brettell E; Crump P; Feilbach A; Hewitt C; Hilken N; Howman A; Hughes T; Ives N; Jarrett H; Mehta S; Record R; Ryan G; Sidile C; Wheatley K; Sheerin ; Brown A; Baines LA; Lordan J; Pusey C; Tanna A; McAdoo S; Levy J; Griffith M; Klebe B; Doulton T; Warwick G; Burton J; Barratt J; Topham P; Baines R; Brunskill N; Al-Jayyousi R; Hamilton P; Patel M; Mitra S; Brown N; Sharples E; Luqmani R; Harper L; Rhodes B; Chanouzas D; Morgan M; Hewins P; Floßmann O; Bhandary N; Foxton J; Jones L; King J; Smyth L; D’Souza R; Haigh R; Hough M; Smyth L; Haigh R; Hough M; Salama A; Burns A; Little M; Dhaun N; Dhaygude A; Basnayake K; Iggo N; Jones D; Oliveira D; MacPhee IAM; Dunn E; Lewington AJP; Fan SL; Rajakariar R; Yaqoob M; Short A; Geddes C; Mackinnon B; Jardine AG; Monach P; Merkel PA; Amudala N; Quillen K; Weisman M; Wallace D; Forbess L; Venuturupalli S; Langford C; Hajj-Ali R; Koo A; Hoffman G; Specks U; Keogh K; Ytterberg S; Winters J; Warrington K; Cartin-Ceba R; Peikert T; Fervenza F; Baqir M; Nachman P; Detwiler R; Mottl A; Derebail V; McGregor J; Merkel PA; Sreih A; Rhee R; McAlear C; Aqui N; Moreland L; Kiss J; Liang K; Mohan N; Balogun R; Li T; Brasington R, 2025, 'The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial', Kidney International, 107, pp. 558 - 567, http://dx.doi.org/10.1016/j.kint.2024.11.029

Sasaki T; Buizen L; Harris K; Badve S; Chalmers JP; Gallagher MP; Ha JTK; Jardine M; Ketema DB; Kotwal SS; Neuen BL; Ronksley PE; Wallace H; Yokoo T; Woodward M; Jun M, 2025, 'Variability in eGFR and Adverse Kidney Outcomes in Routine Clinical Practice', Journal of the American Society of Nephrology, 36, pp. 10.1681/asn.2025wn84xd9r, http://dx.doi.org/10.1681/asn.2025wn84xd9r

Kotwal S; Jeyaruban A; Bose B; Lee V; Jardine M; MALLAWARCHCHI A; Ritchie A; Wong M-G; Makris A; Badve S; Siriwardana A; Yong K; Perkovic V, 2025, 'WCN25-1567 Glomerular disease registry and Biobank (GRIT)– design and baseline results', Kidney International Reports, 10, pp. s196 - s197, http://dx.doi.org/10.1016/j.ekir.2024.11.382

Yeung WCG; Toussaint ND; Lioufas N; Hawley CM; Pascoe EM; Elder GJ; Valks A; Badve SV, 2024, 'Vitamin D status and intermediate vascular and bone outcomes in chronic kidney disease: a secondary post hoc analysis of IMPROVE-CKD', Internal Medicine Journal, 54, pp. 1960 - 1969, http://dx.doi.org/10.1111/imj.16516

Neuen BL; Ostrominski JW; Claggett B; Beldhuis IE; Chatur S; McCausland FR; Badve SV; Arnott C; Heerspink HJL; Jun M; Falster M; de Oliveira Costa J; Pollock C; Jardine MJ; Mahaffey KW; Perkovic V; Solomon SD; Vaduganathan M, 2024, 'Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes', Journal of the American College of Cardiology, 84, pp. 2246 - 2250, http://dx.doi.org/10.1016/j.jacc.2024.08.006

Neuen BL; Fletcher RA; Heath L; Perkovic A; Vaduganathan M; Badve SV; Tuttle KR; Pratley R; Gerstein HC; Perkovic V; Heerspink HJL, 2024, 'Cardiovascular, Kidney, and Safety Outcomes with GLP-1 Receptor Agonists Alone and in Combination with SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis', Circulation, 150, pp. 1781 - 1790, http://dx.doi.org/10.1161/CIRCULATIONAHA.124.071689

Neuen BL; Badve SV; Arnott C, 2024, 'Optimizing Clinical Outcomes Beyond Heart Failure With Intravenous Iron', Journal of the American College of Cardiology, 84, pp. 1718 - 1720, http://dx.doi.org/10.1016/j.jacc.2024.09.013

Ha JT; Hiremath S; Jun M; Green SC; Wheeler DC; Coyne DW; Perkovic V; Badve SV, 2024, 'Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease', Nejm Evidence, 3, http://dx.doi.org/10.1056/EVIDoa2300189

Back to profile page